Rare diseases
Investigational molecules
Locations
Back to Norway14 clinical trials in Gjoevik, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
NorwayStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
NorwayStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
NorwayEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
NorwayStudy on the Safety and Effectiveness of Nivolumab, Pembrolizumab, and Cemiplimab with Radiotherapy for Stage IV Non-Small Cell Lung Cancer Patients
NorwayStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
NorwayStudy of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss
NorwayStudy Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older
NorwayStudy on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone
NorwayStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
NorwayStudy of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer
NorwayThe busiest research cities in the country
What the registry says about research in the country
Studies focused on evaluating innovative treatments for inflammatory bowel diseases, including trials assessing combination therapies and long-term effectiveness of medications for ulcerative colitis and Crohn's disease.
Multiple trials are investigating dual-therapy approaches and novel compounds for improved disease control.
Research examining advanced treatments for stroke prevention and management, particularly in patients with atrial fibrillation and those using anticoagulation therapy.
Innovative approaches to thrombolysis and stroke prevention are being evaluated through various clinical protocols.
Comprehensive research into lung cancer treatments, including studies on small-cell and non-small cell lung cancer, investigating combination approaches with immunotherapy and radiotherapy.
Focus on improving survival rates through innovative therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
